LIVE MARKETS-Healthcare shines as AI trade eases    

By Reuters News

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

HEALTHCARE SHINES AS AI TRADE EASES

US stocks are modestly higher early Tuesday as a rebound in oil prices and another round of selling in AI-linked shares weigh on the market. Traders are also positioning ahead of several major earnings reports due later this week.

While the headline indexes are modestly higher, the action beneath the surface is even more constructive. Most S&P 500 sectors are higher, led by healthcare .SPXHC, which is up around 2% and on track for a record closing high. Real estate .SPLRCR, utilities .SPLRCU, and financials .SPSY are also posting gains of more than 1%.

Materials .SPLRCM, off only around 0.4%, is the weakest group.

Lower Treasury yields are helping support several groups, including big banks .SPXBK, regional banks .KRX, biotech .NBI, housing-related stocks .HGX and small caps .RUT as the US 10-year yield falls back toward 5.10%.

After falling more than 2% earlier in the session, chip stocks .SOX have pared their losses and are now around flat on the day.

Here is a snapshot of where markets stood around 10:05 a.m. ET.

(Terence Gabriel)

*****

EARLIER ON LIVE MARKETS:

S&P 500 STALLS NEAR RECORDS; KEY LEVELS IN FOCUS CLICK HERE

BYE-BYE SAASPOCALYPSE? SAP CHARTS TURN BULLISH AHEAD OF EARNINGS CLICK HERE

CAN TIGHT CREDIT SAVE AI? CLICK HERE

TIME FOR LUXURY TO GIVE UP ON CHINA BOUNCEBACK CLICK HERE

LNG WAVE COMING, JUST NOT RIGHT NOW CLICK HERE

GENERALISED SELLING; AI WORRIES SIMMERING CLICK HERE

EUROPE BEFORE THE BELL: LOTS OF WORRIES TO CHOOSE FROM CLICK HERE

MORNING BID: KOREAN CANARY IN THE AI COALMINE CLICK HERE


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.